The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 12, 2022

Filed:

May. 28, 2020
Applicant:

National University Corporation Tokyo Medical and Dental University, Tokyo, JP;

Inventors:

Emi Nishimura, Tokyo, JP;

Hiroyuki Matsumura, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/713 (2006.01); A61K 38/55 (2006.01); A61K 36/05 (2006.01); A61K 36/14 (2006.01); A61K 36/47 (2006.01); A61K 36/48 (2006.01); A61K 36/54 (2006.01); A61K 8/97 (2017.01); A61K 31/506 (2006.01); A61K 36/489 (2006.01); A61K 36/738 (2006.01); A61K 36/04 (2006.01); A61K 36/424 (2006.01); A61Q 5/00 (2006.01); A61K 48/00 (2006.01); A61K 31/7088 (2006.01); C12Q 1/37 (2006.01); A61K 36/30 (2006.01); A61K 36/74 (2006.01); A61K 36/23 (2006.01); A61K 36/60 (2006.01); A61K 36/185 (2006.01); A61Q 7/00 (2006.01); A61K 36/718 (2006.01); A61K 36/488 (2006.01); A61K 36/53 (2006.01); A61K 36/82 (2006.01); A61K 39/395 (2006.01); A61K 36/18 (2006.01); A61K 36/28 (2006.01); A61K 31/222 (2006.01); A61K 45/00 (2006.01); A61P 17/14 (2006.01); A61K 31/05 (2006.01); A61K 31/16 (2006.01); A61K 31/355 (2006.01); A61K 31/375 (2006.01); A61K 31/381 (2006.01); A61K 31/7048 (2006.01); A61K 31/13 (2006.01); A61K 36/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/713 (2013.01); A61K 8/97 (2013.01); A61K 31/05 (2013.01); A61K 31/16 (2013.01); A61K 31/222 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/381 (2013.01); A61K 31/506 (2013.01); A61K 31/7048 (2013.01); A61K 31/7088 (2013.01); A61K 36/04 (2013.01); A61K 36/05 (2013.01); A61K 36/14 (2013.01); A61K 36/18 (2013.01); A61K 36/185 (2013.01); A61K 36/23 (2013.01); A61K 36/28 (2013.01); A61K 36/30 (2013.01); A61K 36/424 (2013.01); A61K 36/47 (2013.01); A61K 36/48 (2013.01); A61K 36/488 (2013.01); A61K 36/489 (2013.01); A61K 36/53 (2013.01); A61K 36/54 (2013.01); A61K 36/60 (2013.01); A61K 36/718 (2013.01); A61K 36/738 (2013.01); A61K 36/74 (2013.01); A61K 36/82 (2013.01); A61K 38/55 (2013.01); A61K 39/395 (2013.01); A61K 45/00 (2013.01); A61K 48/00 (2013.01); A61P 17/14 (2018.01); A61Q 5/00 (2013.01); A61Q 7/00 (2013.01); C12Q 1/37 (2013.01); A61K 31/13 (2013.01); A61K 36/00 (2013.01);
Abstract

The present invention provides novel compositions for suppressing or improving hair loss, and compositions for suppressing or improving graying. More specifically, it provides agents that stabilize type XVII collagen expression, preferably agents that suppress the degradation of type XVII collagen by ELANE inhibitors and such, and compositions comprising a DNA repair-promoting agent or a DNA damage-suppressing agent as an active ingredient. Advantageous suppressive effects of hair loss and graying can be obtained when a composition comprising as an active ingredient a suppressive agent of type XVII collagen degradation such as an ELANE inhibitor is administered to a mammal. For the ELANE inhibitors, suppressive agents of type XVII collagen degradation and DNA repair-promoting agents, low-molecular compounds, polypeptides, proteins, antibodies, or nucleic acid medicine such as antisense oligos or siRNAs may be used. A method of screening for effective substances for suppression of hair loss and graying is also provided.


Find Patent Forward Citations

Loading…